Risk Prediction Model for Synchronous Oligometastatic Non-Small Cell Lung Cancer: Thoracic Radiotherapy May Not Prolong Survival in High-Risk patients

BACKGROUND AND PURPOSE: On the basis of the promising clinical study results, thoracic radiotherapy (TRT) has become an integral part of treatment of synchronous oligometastatic non–small cell lung cancer (SOM-NSCLC). However, some of them experienced rapid disease progression after TRT and showed n...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Chunliu, Wang, Fang, Tian, Jia, Wei, Jia, Li, Xue, Ren, Kai, Xu, Liming, Zhao, Lujun, Wang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337860/
https://www.ncbi.nlm.nih.gov/pubmed/35912173
http://dx.doi.org/10.3389/fonc.2022.897329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337860/
https://www.ncbi.nlm.nih.gov/pubmed/35912173
http://dx.doi.org/10.3389/fonc.2022.897329

Ejemplares similares